Home
Mail
Search
News
Finance
Sport
Lifestyle
Celebrity
Movies
Weather
Mobile
More
Yahoo
Mail
Cryptocurrencies
News
Property
Money
Markets
Industries
Watchlists
My Portfolio
My Screeners
Singapore markets open in 2 hours 24 minutes
Straits Times Index
3,296.89
+4.20
(+0.13%)
S&P 500
5,064.20
+45.81
(+0.91%)
Dow
38,225.66
+322.37
(+0.85%)
Nasdaq
15,840.96
+235.48
(+1.51%)
Bitcoin USD
59,252.01
+1,335.07
(+2.31%)
CMC Crypto 200
1,280.01
+9.26
(+0.73%)
Theravance Biopharma, Inc. (TBPH)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
9.37
+0.53
(+6.00%)
At close: 04:00PM EDT
9.10
-0.27
(-2.88%)
After hours:
06:05PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
57,424
57,424
51,346
55,311
71,857
Cost of revenue
-
-
-
-
0
Gross profit
-
-
-
-
71,857
Operating expenses
Research development
40,621
40,621
63,392
193,657
260,953
Selling general and administrative
70,095
70,452
74,071
107,658
108,531
Total operating expenses
110,716
111,073
137,463
301,315
369,484
Operating income or loss
-53,292
-53,649
-86,117
-246,004
-297,627
Interest expense
2,350
2,350
6,369
8,547
8,547
Total other income/expenses net
-2,743
-2,386
-8,874
-11,780
-1,610
Income before tax
-49,269
-49,269
-92,815
-265,222
-303,343
Income tax expense
5,924
5,924
9
-151
-8,520
Income from continuing operations
-55,193
-55,193
-92,824
-265,071
-294,823
Net income
-55,193
-55,193
872,132
-199,426
-278,017
Net income available to common shareholders
-55,193
-55,193
872,132
-199,426
-278,017
Basic EPS
-0.62
-
11.85
-2.87
-4.46
Diluted EPS
-0.62
-
11.85
-2.87
-4.46
Basic average shares
59,798
-
73,591
69,461
62,345
Diluted average shares
59,798
-
73,591
69,461
62,345
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.